Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Celiac Disease

• Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease
• A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
• A Study to Assess the Safety of TPM502 in Adults With Celiac Disease
• Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
• Tryptophan for Impaired AhR Signaling in Celiac Disease
• A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease
• Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
• A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
• Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
• Study of Latiglutenase in T1D/CD Patients
• Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease
• AN-PEP on Gluten Exposure in Celiacs
• A Study of Guselkumab in Adult Participants With Celiac Disease
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole
• Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
• PTG-100 for Patients With Celiac Disease
• Assessment of KAN-101 in Celiac Disease (ACeD)
• Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
• Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients
• Budesonide in Patients With Immune Mediated Enteropathies
• Assessment of the Effect of Gluten Free Toothpaste on the Ulcerative Events in Children With Celiac Disease
• Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
• A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease
• Latiglutenase as a Treatment for Celiac Disease
• Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
• Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
• Differences in Preparation for Small Bowel Capsule Endoscopy
• Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
• Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease
• Vedolizumab Induction May Prevent Celiac Enteritis
• Sucrosomial Iron in Patients With Celiac Disease and IDA
• Prucalopride Prior to Small Bowel Capsule Endoscopy
• A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease
• Pancreatic Enzyme Supplementation for Celiac Disease
• Cytokine Profile in Children With Celiac Disease
• Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.
• Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
• Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase
• Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration
• A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
• Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease
• Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease
• Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients
• Study of Enzyme Supplements to Treat Celiac Disease
• Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
• Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
• A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
• Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
• A Phase II Study of CCX282-B in Patients With Celiac Disease
• Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
• Safety Study of Larazotide Acetate to Treat Celiac Disease.
• Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects